Enanta Pharmaceuticals, Inc. Share Price
ENTAEnanta Pharmaceuticals, Inc. Stock Performance
Open $13.38 | Prev. Close $13.15 | Circuit Range N/A |
Day Range $13.21 - $13.60 | Year Range $6.46 - $17.11 | Volume 6,056 |
Average Traded $13.39 |
Enanta Pharmaceuticals, Inc. Share Price Chart
About Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
Enanta Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
21-Jul-26 | $13.38 | $13.40 | +0.00% |
21-Jul-26 | $13.38 | $13.40 | +1.90% |
20-Jul-26 | $13.79 | $13.15 | -4.33% |
17-Jul-26 | $13.37 | $13.74 | +4.29% |
16-Jul-26 | $13.09 | $13.18 | -0.60% |
15-Jul-26 | $12.88 | $13.26 | +0.91% |
14-Jul-26 | $13.66 | $13.14 | -4.09% |
FAQs on Enanta Pharmaceuticals, Inc. Share Price
Can I buy Enanta Pharmaceuticals, Inc. shares in India?
What is the share price of Enanta Pharmaceuticals, Inc.?
What is the 5 year returns of Enanta Pharmaceuticals, Inc.?
What are the high & low stock price of Enanta Pharmaceuticals, Inc. today?
What is the 52-week high and low of Enanta Pharmaceuticals, Inc. stock?